- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
IQVIA Holdings Inc (IQV)IQVIA Holdings Inc stock price live, this page displays NYSE IQV stock exchange data. View the IQV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the IQVIA Holdings Inc real time stock price chart below.
What Is the IQVIA Holdings Inc Stock Price Today?
The IQVIA Holdings Inc stock price today is 200.84.
What Is the Stock Symbol for IQVIA Holdings Inc?
The stock symbol for IQVIA Holdings Inc is "IQV."
What Stock Exchange Does IQVIA Holdings Inc Trade On?
IQVIA Holdings Inc is listed and trades on the NYSE stock exchange.
Is IQVIA Holdings Inc a Good Stock to Buy?
Determining whether IQVIA Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IQV quote. (ISIN: US46266C1053)
What Is the IQVIA Holdings Inc Stock Price Today?
The IQVIA Holdings Inc stock price today is 200.84.
What Is the Stock Symbol for IQVIA Holdings Inc?
The stock symbol for IQVIA Holdings Inc is "IQV."
What Stock Exchange Does IQVIA Holdings Inc Trade On?
IQVIA Holdings Inc is listed and trades on the NYSE stock exchange.
Is IQVIA Holdings Inc a Good Stock to Buy?
Determining whether IQVIA Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IQV quote. (ISIN: US46266C1053)
Currency in USD
200.84
-0.59(-0.29%)
Closed
Pre Market
201.93+1.09(+0.54%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
200.38
202.66
52 wk Range
187.62
261.73
IQV Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
200.38202.66
52 wk Range
187.62261.73
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockIQV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Price Target
252.18
Upside
+25.56%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
15 analysts have revised their earnings downwards for the upcoming period
- Quintis Trl Hlgs receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Quintis Trl Hlgs receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Quintis Trl Hlgs receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Quintis Trl Hlgs receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Quintis Trl Hlgs receives Investment Bank Analyst Rating Update
- Investing.com
Pro
IQVIA Holdings Company Profile
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients’ outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.
IQVIA Holdings Inc SWOT Analysis
Data-Driven Giant | Explore IQVIA's unique position as the world's largest Contract Research Organization, leveraging proprietary data and advanced technology in biopharmaceutical services |
Financial Resilience | IQVIA demonstrates strength amid industry challenges, with analysts projecting EPS growth from $11.13 in FY2024 to $12.22 in FY2025 |
Market Leadership | Delve into IQVIA's competitive edge, stemming from unparalleled healthcare data access and analytics capabilities, positioning it for long-term success |
Future Prospects | Analyst price targets range from $260 to $275, reflecting optimism about IQVIA's potential to capitalize on growing demand for data analytics in drug development |
IQV Full Pro Research
Institutional-Grade Stock Analysis
Understand how IQV earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks
IQVIA Holdings Inc Earnings Call Summary for Q3/2024
- IQVIA's Q2 2024 revenue up 2.3% YoY to $3,814M; adjusted EPS grew 8.6%. 5% growth excluding forex and COVID impacts.
- TAS segment forecast to grow 6-7% in H2; R&DS achieved record backlog from strong net new bookings.
- Full-year revenue guidance: $15,425M-$15,525M. Company confident in growth across business segments.
- AI and analytics solutions key to winning healthcare contracts; focus on mission-critical projects and new drug launches.
- Strong cash flow reduced leverage to 3.25x EBITDA; market caution persists with clients maintaining budgetary discipline.
Last Updated: 23-07-2024, 07:46 pm
Read Full TranscriptCompare IQV to Peers and Sector
Metrics to compare | IQV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIQVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 25.9x | −6.8x | −0.7x | |
PEG Ratio | 0.93 | −1.20 | 0.00 | |
Price/Book | 5.2x | 1.3x | 2.6x | |
Price / LTM Sales | 2.4x | 2.1x | 3.2x | |
Upside (Analyst Target) | 27.0% | 23.0% | 40.8% | |
Fair Value Upside | Unlock | 1.5% | 5.7% | Unlock |
Analysts' Recommendations
21 Buy
4 Hold
0 Sell
Ratings:
23 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 252.18
(+25.56% Upside)
FAQ
What Is the IQVIA Holdings (IQV) Stock Price Today?
The IQVIA Holdings stock price today is 200.84.
What Stock Exchange Does IQVIA Holdings Trade On?
IQVIA Holdings is listed and trades on the NYSE stock exchange.
What Is the Stock Symbol for IQVIA Holdings?
The stock symbol for IQVIA Holdings is "IQV."
What Is the IQVIA Holdings Market Cap?
As of today, IQVIA Holdings market cap is 36.45B.
What is IQVIA Holdings Earnings Per Share?
The IQVIA Holdings EPS is 7.72.
What Is the Next IQVIA Holdings Earnings Date?
IQVIA Holdings will release its next earnings report on 11 Feb 2025.
From a Technical Analysis Perspective, Is IQV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.